KR100686351B1 - Method of preparing racemic tolterodine - Google Patents

Method of preparing racemic tolterodine Download PDF

Info

Publication number
KR100686351B1
KR100686351B1 KR1020060003528A KR20060003528A KR100686351B1 KR 100686351 B1 KR100686351 B1 KR 100686351B1 KR 1020060003528 A KR1020060003528 A KR 1020060003528A KR 20060003528 A KR20060003528 A KR 20060003528A KR 100686351 B1 KR100686351 B1 KR 100686351B1
Authority
KR
South Korea
Prior art keywords
phenyl
alkyl
formula
hydroxy
represented
Prior art date
Application number
KR1020060003528A
Other languages
Korean (ko)
Inventor
김경수
박영준
Original Assignee
주식회사 카이로제닉스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 카이로제닉스 filed Critical 주식회사 카이로제닉스
Priority to KR1020060003528A priority Critical patent/KR100686351B1/en
Application granted granted Critical
Publication of KR100686351B1 publication Critical patent/KR100686351B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Abstract

Provided is a method for preparing tolterodine racemate, which mass-produces high-purity tolterodine racemate in a simple and economical manner without using toxic reagents or high-pressure hydrogen. The method for preparing N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropaneamine(tolterodine racemate) represented by the following formula (I) comprises the steps of: (1) reacting 6-methyl-4-phenyl-3,4-dihydrocoumarin with sodium borohydride to prepare 2-(3-hydroxy-1-phenyl-propyl)-4-methylphenol; (2) reacting the prepared 2-(3-hydroxy-1-phenyl-propyl)-4-methylphenol with alkyl or aryl sulfonyl chloride and triethylamine, and N,N-diisopropylamine in order to prepare a compound represented by the following formula (V), in the alkyl or aryl sulfonyl chloride in which an alkyl group is a C1-4 alkyl group and an aryl group is a phenyl group or a C1-3 alkyl-substituted phenyl group; and (3) reacting the compound represented by the formula (V) with hydroxide of alkali metal.

Description

톨테로딘 라세미체의 제조방법{Method of Preparing Racemic Tolterodine}Method for preparing tolterodine racemate {Method of Preparing Racemic Tolterodine}

본 발명은 톨테로딘 라세미체의 제조방법에 관한 것이다. 보다 구체적으로, 본 발명은 화학식 (II)로 표시되는 무스카린 수용체 길항제인 (R)-N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민(톨테로딘)의 핵심중간체인 화학식 (I)로 표시되는 톨테로딘 라세미체의 새로운 제조방법에 관한 것이다. The present invention relates to a process for the preparation of tolterodine racemates. More specifically, the present invention relates to (R) -N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine, which is a muscarinic receptor antagonist represented by the formula (II) ( It relates to a novel method for preparing tolterodine racemate represented by formula (I) which is a key intermediate of tolterodine).

요실금이라 불리는 증상은 자신의 의지와 상관없이 요도를 통해 소변이 나오는 증상으로서, 상당수의 성인인구가 요실금으로 고생하고 있다. 특히 절박성 요실금은 방광이 과도하게 활성화되어 방광에 소변이 채워지는 동안 방광의 근육막을 형성하는 평활근 섬유다발 수축이 정상적으로 제어되지 못하여 발생하는 것으로 추측된다. 최근에 개발된 톨테로딘은 빈뇨, 절박뇨 또는 절박성 요실금과 같은 과활동성 방광에 대한 우수한 치료 효과가 있다는 임상 결과가 발표됨에 따라 이의 치료제로 주목받고 있다. Urinary incontinence is a condition in which urine flows out of the urethra regardless of one's intention. In particular, urge urinary incontinence is thought to be caused by uncontrolled smooth muscle fiber bundle contraction, which forms the muscle membrane of the bladder while the bladder is excessively activated to fill the bladder with urine. The recent development of tolterodine has attracted attention as a therapeutic agent for it, with clinical results showing that there is an excellent therapeutic effect on overactive bladder such as urinary, urgency, or urinary incontinence.

Figure 112006002273936-pat00002
Figure 112006002273936-pat00003
Figure 112006002273936-pat00002
Figure 112006002273936-pat00003

톨테로딘 또는 이의 유사체들의 제조 방법은 미국 특허 제5382600호(Pharmacia Aktiebolag), 대한민국 특허 제0463614호 (Pharmacia & Upjohn Company) 및 미국특허출원 제2001/0016669호 (Pher G. Andersson) 등에 개시되어 있다. Methods for preparing tolterodine or analogs thereof are disclosed in U.S. Pat.

상기 문헌에 개시된 톨테로딘의 제조 방법들을 요약하면 다음과 같다. The method for preparing tolterodine disclosed in the above document is summarized as follows.

미국 특허 제5382600호는 다음과 같은 톨테로딘의 초기 제조방법을 소개하고 있다: 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 개환 반응시키고, 리튬알루미늄히드리드로 환원시키고, 알코올을 토실화하고, 디이소프로필아민과 반응시키고, 디메틸화하여 얻어진 톨테로딘 라세미체를 제조하는 방법이다. 이때 얻어진 톨테로딘 라세미체는 L(+)-타타릭산으로 단리하여 화학식 (II)으로 표시되는 순수한 톨테로딘을 제조한다 (하기 반응식 1 참조). 이 방법은 반응공정이 매우 많으며 대량합성공정에서 사용하기 어려운 시약(예: 리튬알루미늄히드리드, 트리브로모보레인 등) 들이 다수 사용되는 문제점이 있다. US Pat. No. 5,532,600 introduces an initial method for preparing tolterodine as follows: ring-opening reaction of 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by formula (III) and lithium aluminum hydroxide It is a method of producing the tolterodine racemate obtained by reducing with lead, tosylating alcohol, reacting with diisopropylamine, and dimethylating. The tolterodine racemate obtained at this time is isolated by L (+)-tatariic acid to prepare pure tolterodine represented by the formula (II) (see Scheme 1 below). This method has a problem that there are many reaction processes and many reagents (eg, lithium aluminum hydride, tribromoborane, etc.) which are difficult to use in the mass synthesis process are used.

반응식 1Scheme 1

Figure 112006002273936-pat00004
Figure 112006002273936-pat00004

대한민국 특허 제0463614호의 제조방법은 미국 특허 제5382600호를 개량한 방법으로 하기 반응식 2에 나타낸 바와 같이 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 환원시켜 상응하는 알코올인 3,4-디하이드로-6-메틸-4-페닐-2H-벤조피린-2-올을 제조하고, 그 알코올을 이소프로필아민과 반응시키고, 그 형성된 라세미체를 분리하여 화학식 (II)로 표시되는 톨테로딘을 단리하여 제조한 다. 이 방법은 반응식 1의 공정보다 개선된 방법으로 반응공정이 대폭 단축되었으나 대량합성공정에서 사용하기 어려운 디이소부틸 알루미늄히드리드와 같은 시약이나 수소반응을 사용해야하는 문제점이 있다. The method of preparing Korean Patent No. 0463614 is an improved method of US Pat. No. 5,538,600 to reduce 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by Formula (III) as shown in Scheme 2 below. Prepare the corresponding alcohol, 3,4-dihydro-6-methyl-4-phenyl-2H-benzopylin-2-ol, react the alcohol with isopropylamine, separate the racemates formed, and It is prepared by isolating tolterodine represented by (II). This method is an improved method than the process of Scheme 1, but the reaction process is greatly shortened, but there is a problem that a reagent or hydrogen reaction, such as diisobutyl aluminum hydride, which is difficult to use in a mass synthesis process, must be used.

반응식 2Scheme 2

Figure 112006002273936-pat00005
Figure 112006002273936-pat00005

미국특허 제2001/0016669호에서는 5-메틸-3-페닐-인데-1-온을 (R)-MeCBS 촉매를 사용하여 카보닐기를 비대칭으로 환원시키고, DABCO를 이용하여 5-메틸-3-(S)-페닐-인단-1-온을 제조하고, mCPBA를 이용하여 6-메틸-4-(S)-페닐-3,4-디히드로쿠마린을 제조하고, 이를 환원시키고, 얻어진 알코올을 디이소프로필아민과 반응시켜 화학식 (II)로 표시되는 톨테로딘을 제조한다. 이 반응은 반응식 1 또는 반응 식 2와 같이 마지막 단계에서 이성질체를 분리하는 대신에 비대칭 환원반응으로 원하는 이성질체만을 만들 수 있다는 점에서 장점이 있으나 합성공정이 많이 늘어나고 대량합성공정에서 사용하기 어려운 시약이나 반응이 다수 사용되어야 하는 문제점을 가지고 있다. U.S. Patent No. 2001/0016669 discloses that 5-methyl-3-phenyl-in-1-one is asymmetrically reduced to a carbonyl group using (R) -MeCBS catalyst, and 5-methyl-3- (using DABCO). S) -phenyl-indan-1-one was prepared, and 6-methyl-4- (S) -phenyl-3,4-dihydrocoumarin was prepared using mCPBA, and the obtained alcohol was reduced to diiso. By reacting with propylamine, tolterodine represented by the formula (II) is prepared. This reaction is advantageous in that it can produce only the desired isomer by asymmetric reduction reaction instead of separating the isomer in the last step as in Scheme 1 or Scheme 2, but the synthesis process is increased and the reagent or reaction that is difficult to use in mass synthesis process This has a number of problems that must be used.

반응식 3Scheme 3

Figure 112006002273936-pat00006
Figure 112006002273936-pat00006

이에 본 발명자들은 상기와 같은 공지 기술의 문제점을 해결하여 보다 단순하고 용이한 공정으로 톨테로딘을 얻기 위하여 연구를 계속한 결과, 하기 반응식 4 에 나타낸 바와 같이 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 소듐보로히드리드(NaBH4)와 반응시켜 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀을 제조하고, 알킬 또는 아릴술포닐 클로라이드 및 트리에틸아민과 N,N-디이소프로필아민을 순차적으로 반응시켜 화학식 (V)로 표시되는 화합물을 제조하고, 수용성 용매 및 물의 혼합용매에서 수산화염을 반응시켜 화학식 (I)로 표시되는 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민을 높은 수율로 쉽게 합성할 수 있다는 사실을 알 수 있었다. Accordingly, the present inventors have continued the research to solve the problems of the known technology as described above to obtain tolterodine in a simpler and easier process, 6-methyl- represented by the formula (III) as shown in Scheme 4 below 2- (3-hydroxy-1-phenyl-propyl) -4-methylphenol represented by the formula (IV) by reacting 4-phenyl-3,4-dihydrocoumarin with sodium borohydride (NaBH 4 ) To prepare a compound represented by the formula (V) by sequentially reacting alkyl or arylsulfonyl chloride and triethylamine and N, N-diisopropylamine, and the hydroxide salt in a mixed solvent of water-soluble solvent and water It was found that N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine represented by the formula (I) can be easily synthesized by high yield.

즉, 본 발명자들은 공지의 방법들 중 반응식 1의 제조공정과 출발물질은 동일하게 사용하면서도, 페놀기의 보호기 도입반응을 별도로 수행하지 않고 N,N-디이소프로필아민을 효과적으로 도입하는 공정을 이용함으로써 합성공정을 획기적으로 개선하였다. 본 발명자들은 페놀기의 보호기 도입반응을 생략하거나 또는 별도의 공정없이 기존 공정에 포함시켜 톨테로딘 라세미체를 합성할 수 있는 방법을 찾는데 중점을 두고 연구하였다. That is, the present inventors use the process of preparing the N-N-diisopropylamine effectively without performing the protecting group introduction reaction of the phenol group, while using the same process and the starting material of the reaction formula 1 of the known methods This drastically improved the synthesis process. The present inventors focused on finding a method for synthesizing tolterodine racemate by omitting the protecting group introduction reaction of the phenol group or by including it in an existing process without a separate process.

그 결과 본 발명자들은 6-메틸-4-페닐-3,4-디히드로쿠마린을 소듐보로히드리드(III)와 반응시켜 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀(IV)을 제조하고, 알킬 또는 아릴술포닐 클로라이드 및 트리에틸아민과 N,N-디이소프로필아민을 순차적으로 반응시켜 화학식 (V)로 표시되는 화합물을 제조하고, 수용성용매 및 물의 혼합용매에서 수산화염을 반응시켜 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민(I)을 높은 수율로 제조하는 방법을 개발하게 되었다.As a result, the inventors reacted 6-methyl-4-phenyl-3,4-dihydrocoumarin with sodium borohydride (III) to give 2- (3-hydroxy-1-phenyl-propyl) -4-methyl Phenol (IV) was prepared, and alkyl or arylsulfonyl chloride and triethylamine were sequentially reacted with N, N-diisopropylamine to prepare a compound represented by the formula (V), and a mixed solvent of an aqueous solvent and water. A method of preparing N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine (I) in high yield by reacting a hydroxide with

따라서, 본 발명에 따르면 선행기술에서 사용된 수분과 접촉시 화재를 유발하는 시약을 사용하거나, 유독성 기체를 발생시키는 시약을 시용하거나, 고압의 수소를 사용하지 않으면서도 반응공정이 단축된 새로운 공정으로 고품질의 화학식 (I)로 표시되는 톨테로딘 라세미체를 제조할 수 있었다. Therefore, according to the present invention, the reaction process is shortened without using a reagent that causes a fire when contacted with water used in the prior art, a reagent that generates a toxic gas, or using high pressure hydrogen. High quality tolterodine racemates represented by formula (I) could be prepared.

본 발명은 무스카린 수용체 길항제인 (R)-N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민(톨테로딘)의 핵심중간체인 톨테로딘 라세미체의 새로운 제조방법에 관한 것이다.The present invention relates to tolterodine racemic, a key intermediate of the muscarinic receptor antagonist (R) -N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine (tolerodine). It relates to a new method for producing a sieve.

본 발명의 목적은 요실금의 치료에 우수한 효과를 나타내는 톨테로딘의 핵심중간체인 톨테로딘 라세미체를 제조하는 새로운 방법을 제공하기 위한 것이다.It is an object of the present invention to provide a novel method for preparing tolterodine racemate, which is a key intermediate of tolterodine, which has an excellent effect on the treatment of urinary incontinence.

본 발명의 다른 목적은 공지기술과는 달리 수분과 접촉시 화재를 유발하는 시약 또는 유독성 기체를 발생시키는 시약을 사용하지 않고, 그리고 고압의 수소를 사용하지 않으면서 6-메틸-4-페닐-3,4-디히드로쿠마린으로부터 세 단계의 반응공정 만을 거쳐 톨테로딘 라세미체를 제조하는 방법을 제공하기 위한 것이다.Another object of the present invention is that, unlike the known art, 6-methyl-4-phenyl-3 does not use a reagent that causes a fire or a toxic gas upon contact with moisture, and does not use high pressure hydrogen. It is to provide a method for preparing tolterodine racemate from a, 4-dihydrocoumarin through a three-step reaction step.

본 발명의 또 다른 목적은 보다 간편하고 경제적으로 고순도의 톨테로딘 라세미체를 고수율로 제조하는 방법을 제공하기 위한 것이다.Still another object of the present invention is to provide a method for producing high purity tolterodine racemates in high yield more simply and economically.

본 발명의 또 다른 목적은 톨테로딘 라세미체를 대량으로 제조하기에 적합한 방법을 제공하기 위한 것이다.Another object of the present invention is to provide a method suitable for the preparation of tolterodine racemates in bulk.

본 발명의 상기 및 기타의 목적들은 하기 설명되는 본 발명에 의하여 모두 달성될 수 있다.The above and other objects of the present invention can be achieved by the present invention described below.

본 발명은 하기 화학식 (I)로 표시되는 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민(톨테로딘 라세미체)를 제조하는 방법에 관한 것이다. 상기 톨테로딘 라세미체는 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 소듐보로히드리드와 반응시켜 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀을 제조하고, 이를 알킬 또는 아릴술포닐 클로라이드 및 트리에틸아민과 N,N-디이소프로필아민을 순차적으로 반응시켜 화학식 (V)로 표시되는 화합물을 제조하고, 수용성 용매 및 물의 혼합용매에서 알칼리 금속의 수산화물과 반응시켜 제조된다.The present invention relates to a method for producing N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine (tolerodine racemate) represented by the following general formula (I) will be. The tolterodine racemate is 2- (3-) represented by formula (IV) by reacting 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by formula (III) with sodium borohydride. Hydroxy-1-phenyl-propyl) -4-methylphenol is prepared, which is sequentially reacted with alkyl or arylsulfonyl chloride and triethylamine with N, N-diisopropylamine, represented by the formula (V). Compounds are prepared and reacted with hydroxides of alkali metals in a mixed solvent of water-soluble solvents and water.

상기의 제조공정에서는 수분과 접촉시 화재를 유발하는 시약이나 유독성 기체를 발생시키는 시약을 사용하지 않고 그리고 고압의 수소를 사용하지 않으면서 반응 완결도를 높이고, 반응공정을 단축하였다. In the above manufacturing process, the reaction completion rate is increased without using a reagent that causes a fire or a toxic gas that is in contact with water, and a high-pressure hydrogen is used, and the reaction process is shortened.

본 발명의 바람직한 구체예를 하기 반응식 4에 도시하였다.Preferred embodiments of the invention are shown in Scheme 4 below.

반응식 4Scheme 4

Figure 112006002273936-pat00007
Figure 112006002273936-pat00007

상기 식에서, R은 C1 내지 C4의 알킬기, 치환되지 않은 페닐기, 또는 C1 내지 C3의 알킬기로 치환된 페닐기이며, 바람직하게는 메틸 또는 p-메틸벤젠이며, M은 리튬, 나트륨, 또는 칼륨과 같은 알칼리 금속이다. Wherein R is a C 1 to C 4 alkyl group, an unsubstituted phenyl group, or a C 1 to C 3 alkyl group substituted, preferably methyl or p-methylbenzene, M is lithium, sodium, or Alkali metals such as potassium.

이하에서, 본 발명을 더욱 상세히 설명한다. In the following, the present invention is described in more detail.

제1단계: 2-(3-히드록시-1-First step: 2- (3-hydroxy-1- 페닐Phenyl -프로필)-4--Propyl) -4- 메틸페놀(IV)의Of methylphenol (IV) 제조 Produce

반응용매 하에서 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 소듐보로히드리드와 반응시켜 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀을 제조한다. 2- (3-hydroxy-1) represented by the formula (IV) by reacting 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by the formula (III) with sodium borohydride under a reaction solvent -Phenyl-propyl) -4-methylphenol is prepared.

반응에 사용되는 용매는 메탄올 또는 에탄올과 같은 저급 알코올이 바람직하며, 이 중 메탄올이 가장 바람직하다. 반응 온도는 40℃ 내지 반응용매의 비점이 며, 바람직하게는 60 내지 65℃이다. 반응 시간은 6시간 내지 36시간 사이이며, 더욱 바람직하게는 12시간 내지 24시간이다. The solvent used for the reaction is preferably a lower alcohol such as methanol or ethanol, of which methanol is most preferred. The reaction temperature is a boiling point of 40 ° C. to the reaction solvent, and preferably 60 to 65 ° C. The reaction time is between 6 hours and 36 hours, more preferably 12 hours to 24 hours.

소듐보로히드리드는 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린에 대하여 2당량 내지 5당량 사용되며, 더욱 바람직하게는 2.5당량 내지 3.0당량 사용된다.Sodium borohydride is used in the amount of 2 to 5 equivalents, more preferably 2.5 to 3.0 equivalents, relative to 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by the formula (III).

상기한 바와 같은 반응을 통하여 얻어진 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀(IV)은 용매를 감압하여 농축시킨 후 에틸아세테이트와 물을 가하고 수층을 산성으로 만들어 추출하고 농축하여 회수할 수 있다. 2- (3-hydroxy-1-phenyl-propyl) -4-methylphenol (IV) obtained through the reaction as described above was concentrated by reducing the solvent under reduced pressure, ethyl acetate and water were added, and the aqueous layer was made acidic and extracted. And concentrated to recover.

제2단계: 화학식 (V)의 화합물 제조Second Step: Preparation of Compound of Formula (V)

반응용매 하에서 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀에 알킬 또는 아릴술포닐 클로라이드 및 트리에틸아민, 그리고 N,N-디이소프로필아민을 순차적으로 반응시켜 화학식 (V)로 표시되는 화합물을 제조한다. 구체적으로는 반응용매 하에서 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀에 알킬 또는 아릴술포닐 클로라이드와 트리에틸아민을 가하여 반응시킨다. 이후 N,N-디이소프로필아민을 가한 후 반응용기를 밀봉하고 반응기를 가온하여 반응기의 내부압력을 고압으로 유지하면서 반응시켜 화학식 (V)로 표시되는 화합물을 제조한다. Alkyl or arylsulfonyl chloride and triethylamine, and N, N-diisopropylamine to 2- (3-hydroxy-1-phenyl-propyl) -4-methylphenol represented by the formula (IV) under the reaction solvent To react sequentially to prepare a compound represented by the formula (V). Specifically, alkyl or arylsulfonyl chloride and triethylamine are added to 2- (3-hydroxy-1-phenyl-propyl) -4-methylphenol represented by the formula (IV) under a reaction solvent. Thereafter, after adding N, N-diisopropylamine, the reaction vessel is sealed and the reactor is heated to react while maintaining the internal pressure of the reactor at a high pressure to prepare a compound represented by the formula (V).

반응에 사용되는 용매는 테트라하이드로푸란, 디이소프로필에테르, 디옥산 등의 에테르류, 아세토니트릴 등의 니트릴류, 디클로로메탄, 클로로포름, 1,2-디클로로에탄 등의 염화 탄화수소류, 디메틸아세트아미드, 디메틸포름아미드 등의 아미 드류로부터 선택하여 사용할 수 있으며, 이 중에서 아세토니트릴이 가장 바람직하다. 사용하는 용매의 양은 반응에 사용되는 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀(IV) 1g에 대하여 5ml 내지 20ml의 비율로 사용되며, 바람직하게는 7ml 내지 10ml의 비율로 사용된다. The solvent used for the reaction includes ethers such as tetrahydrofuran, diisopropyl ether and dioxane, nitriles such as acetonitrile, chloride hydrocarbons such as dichloromethane, chloroform and 1,2-dichloroethane, dimethylacetamide, It can select from amides, such as dimethylformamide, and can use, and acetonitrile is the most preferable among these. The amount of the solvent used is used in a ratio of 5 ml to 20 ml with respect to 1 g of 2- (3-hydroxy-1-phenyl-propyl) -4-methylphenol (IV) used in the reaction, and preferably 7 ml to 10 ml. Used as a ratio.

알킬 또는 아릴술포닐 클로라이드에서, 알킬기는 C1 내지 C4의 알킬기이며, 아릴기는 치환되지 않은 페닐기 또는 C1 내지 C3의 알킬기로 치환된 페닐기이다. 바람직하기는 상기 화합물이 메탄술포닐 클로라이드 또는 p-톨루엔술포닐 클로라이드인 것이다. 화학식 (IV)로 표시되는 화합물과 알킬 또는 아릴술포닐 클로라이드를 반응시킬 때의 온도는 -20℃ 내지 60℃이며, 바람직하게는 0 내지 30℃이다. 반응기를 밀봉한 후 반응기의 외부온도는 60℃내지 120℃이며, 바람직하게는 70 내지 90℃이다. 알킬 또는 아릴술포닐 클로라이드와 반응시킬 때의 반응시간은 반응시작 직후부터 3시간 사이이며, 더욱 바람직하게는 30분 내지 1시간이다. 반응기 밀봉 이후의 반응시간은 12시간부터 96시간 사이이며, 더욱 바람직하게는 24시간 내지 36시간이다. In alkyl or arylsulfonyl chloride, the alkyl group is a C 1 to C 4 alkyl group and the aryl group is an unsubstituted phenyl group or a phenyl group substituted with a C 1 to C 3 alkyl group. Preferably the compound is methanesulfonyl chloride or p-toluenesulfonyl chloride. The temperature at the time of reacting the compound represented by general formula (IV) with alkyl or arylsulfonyl chloride is -20 degreeC-60 degreeC, Preferably it is 0-30 degreeC. The outer temperature of the reactor after sealing the reactor is 60 to 120 ℃, preferably 70 to 90 ℃. The reaction time when reacting with alkyl or arylsulfonyl chloride is between 3 hours immediately after the start of the reaction, more preferably 30 minutes to 1 hour. The reaction time after the reactor sealing is between 12 hours and 96 hours, more preferably between 24 hours and 36 hours.

알킬 또는 아릴술포닐 클로라이드는 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀(IV)에 대하여 2당량 내지 3당량 사용되며, 바람직하게는 2.4당량 사용된다.Alkyl or arylsulfonyl chloride is used in the amount of 2 to 3 equivalents, preferably 2.4 equivalents, relative to 2- (3-hydroxy-1-phenyl-propyl) -4-methylphenol (IV).

트리에틸아민은 알킬 또는 아릴술포닐 클로라이드에 대하여 1당량 내지 1.5당량 사용되며, 바람직하게는 1.2당량 사용된다. Triethylamine is used in the amount of 1 to 1.5 equivalents based on alkyl or arylsulfonyl chloride, preferably 1.2 equivalents.

N,N-디이소프로필아민은 사용되는 반응용매의 1/3 내지 3배의 부피비로 사용 되며, 바람직하게는 동일한 부피로 사용된다. N, N-diisopropylamine is used in the volume ratio of 1/3 to 3 times the reaction solvent used, preferably in the same volume.

상기한 바와 같은 반응을 통하여 얻어진 화학식 (V)로 표시되는 화합물은 용매를 감압하여 농축시킨 후 메틸렌클로라이드와 물을 가하고 수층을 산성으로 만들어 세척하고 농축하여 회수할 수 있다. The compound represented by the formula (V) obtained through the reaction as described above may be recovered by concentrating the solvent under reduced pressure, adding methylene chloride and water, making the aqueous layer acidic, washing and concentrating.

제3단계: N,N-Third Step: N, N- 디이소프로필Diisopropyl -3-(2--3- (2- 하이드록시Hydroxy -5--5- 메틸페닐Methylphenyl )-3-) -3- 페닐프로판아민(I)의Of phenylpropanamine (I) 제조 Produce

반응용매 하에서 화학식 (V)으로 표시되는 화합물에 수산화염을 반응시켜 화학식 (I)로 표시되는 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민을 제조한다.N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine represented by formula (I) by reacting a hydroxide with a compound represented by formula (V) under a reaction solvent To prepare.

반응에 사용되는 용매는 수용성 용매와 물의 혼합용매가 사용되며, 수용성 용매는 테트라하이드로푸란, 아세토니트릴, 에탄올, 메탄올 등으로부터 선택하여 사용할 수 있으며, 이 중에서 메탄올이 가장 바람직하다. 사용되는 수용성 용매와 물의 부피비는 10:1 내지 1:2이며 바람직하게는 3:1 내지 1:1이다. As a solvent used in the reaction, a mixed solvent of a water-soluble solvent and water is used, and the water-soluble solvent can be selected from tetrahydrofuran, acetonitrile, ethanol, methanol, and the like, of which methanol is most preferred. The volume ratio of the water-soluble solvent and water used is 10: 1 to 1: 2 and preferably 3: 1 to 1: 1.

수산화염은 수산화리튬, 수산화나트륨, 수산화칼륨으로부터 선택되는 알칼리 금속의 수산화물이 사용된다. 사용되는 수산화염의 양은 반응에 사용되는 화학식 (V)으로 표시되는 화합물에 대하여 2당량 내지 10당량 사용되며 바람직하게는 3당량 내지 5당량 사용된다. As the hydroxide, an alkali metal hydroxide selected from lithium hydroxide, sodium hydroxide and potassium hydroxide is used. The amount of hydroxide salt used is used in the amount of 2 to 10 equivalents, preferably 3 to 5 equivalents, based on the compound represented by the formula (V) used in the reaction.

바람직한 반응온도는 혼합용매의 비등점이다. 반응시간은 1시간부터 10시간 사이이며, 더욱 바람직하게는 3시간 내지 6시간이다. Preferred reaction temperatures are the boiling points of the mixed solvents. The reaction time is between 1 hour and 10 hours, more preferably 3 hours to 6 hours.

상기한 바와 같은 반응을 통하여 얻어진 화학식 (I)로 표시되는 N,N-디이소 프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민은 용매를 감압하여 유기용매를 제거한 후 에틸아세테이트로 추출하여 회수할 수 있다. N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine represented by formula (I) obtained through the reaction as described above was removed under reduced pressure to remove the organic solvent. After extraction with ethyl acetate can be recovered.

상기한 바와 같이 본 발명에 따라, 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 소듐보로히드리드와 반응시켜 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀을 제조하고, 알킬 또는 아릴술포닐 클로라이드와 N,N-디이소프로필아민을 순차적으로 반응시켜 화학식 (V)로 표시되는 화합물을 제조하고, 수용성 유기용매와 물의 혼합용매에서 수산화염을 반응시켜 화학식 (I)로 표시되는 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민을 높은 수율로 쉽게 합성할 수 있다.As described above, according to the present invention, 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by formula (III) is reacted with sodium borohydride to form 2- ( 3-hydroxy-1-phenyl-propyl) -4-methylphenol is prepared, and a compound represented by the formula (V) is prepared by sequentially reacting alkyl or arylsulfonyl chloride with N, N-diisopropylamine. And reacting the hydroxide salt in a mixed solvent of a water-soluble organic solvent and water to increase the N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine represented by the formula (I). Easily synthesized in yield.

상기한 바와 같이 본 발명에 따른 제조방법은 대량합성공정에서 사용하기 어려운 시약이나 공정을 사용하지 않음으로써 합성공정을 용이하게 진행할 수 있었으며 페놀기의 보호기 도입반응을 별도의 공정없이 기존 공정에 포함하여 수행함으로써 합성공정을 단축할 수 있다. As described above, the production method according to the present invention could easily proceed with the synthesis process by not using reagents or processes that are difficult to use in the mass synthesis process, and include the protection group introduction reaction of the phenol group in the existing process without a separate process. By performing the synthesis process can be shortened.

본 발명은 하기의 실시예에 의하여 보다 더 잘 이해될 수 있으며, 하기의 실시예는 본 발명을 예시하기 위한 것이며 첨부된 특허청구범위에 의하여 한정되는 보호범위를 제한하고자 하는 것은 아니다.The invention can be better understood by the following examples, which are intended to illustrate the invention and are not intended to limit the scope of protection defined by the appended claims.

실시예Example

실시예Example 1: 2-(3-히드록시-1- 1: 2- (3-hydroxy-1- 페닐Phenyl -프로필)-4--Propyl) -4- 메틸페놀(IV)의Of methylphenol (IV) 제조 Produce

6-메틸-4-페닐-3,4-디히드로쿠마린 50g (209.83mmol)을 메탄올 800ml에 용해시킨 후 실온에서 소듐보로히드리드 23.8g (629.49mmol)을 서서히 가했다. 실온에 서 30분간 교반한 후 반응용액의 온도를 서서히 올려 24시간 동안 환류하였다. 반응용액을 냉각시키고 감압하에서 제거하였다. 얻어진 잔사에 물 400ml와 진한 염산 10ml를 가한 후 에틸아세테이트로 추출하였다. 얻어진 유기층을 물 300ml로 세척한 후 무수 황산 마그네슘으로 건조시키고 감압 하에서 농축시켜 오일상 고체인 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀 49g(수율 96.4%)을 얻었다. 50 g (209.83 mmol) of 6-methyl-4-phenyl-3,4-dihydrocoumarin was dissolved in 800 ml of methanol, followed by the slow addition of 23.8 g (629.49 mmol) of sodium borohydride at room temperature. After stirring at room temperature for 30 minutes, the temperature of the reaction solution was gradually raised to reflux for 24 hours. The reaction solution was cooled down and removed under reduced pressure. 400 ml of water and 10 ml of concentrated hydrochloric acid were added to the obtained residue, followed by extraction with ethyl acetate. The obtained organic layer was washed with 300 ml of water, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 49 g of 2- (3-hydroxy-1-phenyl-propyl) -4-methylphenol as an oily solid (yield 96.4%). .

1H NMR (CDCl3) δ=2.04 (m, 1H), 2.14 (s, 3H), 3.53 (m, 1H), 3.76 (m, 1H), 4.56(q, 1H), 6.73 (d, 1H), 6.76 (d, 1H), 6.84 (dd, 1H), 7.18 (m, 1H), 7.26 (m, 4H) 1 H NMR (CDCl 3 ) δ = 2.04 (m, 1H), 2.14 (s, 3H), 3.53 (m, 1H), 3.76 (m, 1H), 4.56 (q, 1H), 6.73 (d, 1H) , 6.76 (d, 1H), 6.84 (dd, 1H), 7.18 (m, 1H), 7.26 (m, 4H)

실시예Example 2: 2-(3- 2: 2- (3- 메탄술포닐옥시Methanesulfonyloxy -1--One- 페닐Phenyl -프로필)-4--Propyl) -4- 메틸페놀(V)의Of methylphenol (V) 제조 1 Manufacture 1

실시예 1에서 얻어진 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀 40g (165.07mmol)을 고압반응기내에서 아세토니트릴 300ml에 용해시킨 후 빙냉하에서 트리에틸아민 40.09g (396.17mmol)과 메탄술포닐 클로라이드 41.60g (363.15mmol)을 순차적으로 가하였다. 반응용액의 온도를 서서히 실온으로 올리면서 1시간 동안 교반한 후 N,N-디이소프로필아민 300ml를 가하고 반응용기를 밀봉하였다. 고압반응기의 외부온도를 80℃로 올려 60시간 동안 교반한 후 반응기의 온도를 다시 실온으로 냉각하였다. 용매를 감압하에서 제거한 후 디클로로메탄 600ml를 가하고 묽은 수산화나트륨 수용액 300ml와 묽은 염산 용액 300ml를 사용하여 순차적으로 세척하였다. 용매를 감압하에서 제거하여 묽은 염산용액 500ml에 녹인 후 디이소프로필 에테르 300ml로 세척하고 수산화나트륨을 가하여 수용액을 염기성으로 전환시켰다. 수용액을 디클로로메탄 600ml롤 추출한 후 무수 황산 마그네슘으로 건조시키고 감압 하에서 농축시켜 오일상의 2-(3-메탄술포닐옥시-1-페닐-프로필)-4-메틸페놀 50.0g(수율 75.0%)을 얻었다. 40 g (165.07 mmol) of 2- (3-hydroxy-1-phenyl-propyl) -4-methylphenol obtained in Example 1 were dissolved in 300 ml of acetonitrile in a high-pressure reactor, and then 40.09 g (396.17) of triethylamine under ice-cooling. mmol) and 41.60 g (363.15 mmol) of methanesulfonyl chloride were added sequentially. After stirring for 1 hour while gradually raising the temperature of the reaction solution to room temperature, 300 ml of N, N-diisopropylamine was added and the reaction vessel was sealed. After raising the external temperature of the high-pressure reactor to 80 ° C and stirring for 60 hours, the temperature of the reactor was cooled to room temperature again. After the solvent was removed under reduced pressure, 600 ml of dichloromethane was added, and the mixture was washed sequentially using 300 ml of diluted aqueous sodium hydroxide solution and 300 ml of diluted hydrochloric acid solution. The solvent was removed under reduced pressure, dissolved in 500 ml of dilute hydrochloric acid solution, washed with 300 ml of diisopropyl ether, and sodium hydroxide was added to convert the aqueous solution to basic. The aqueous solution was extracted with 600 ml of dichloromethane, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give 50.0 g (yield 75.0%) of 2- (3-methanesulfonyloxy-1-phenyl-propyl) -4-methylphenol as an oil. .

1H NMR (CDCl3) δ=0.93 (d, 12H), 2.11 (s, 3H), 2.13 (m, 2H), 2.33 (m, 2H), 2.78(s, 3H), 2.97 (m, 2H), 4.32 (t, 1H), 6.80 (m, 1H), 7.03 (d, 1H), 7.17 (m, 1H), 7.26 (m, 4H) 1 H NMR (CDCl 3 ) δ = 0.93 (d, 12H), 2.11 (s, 3H), 2.13 (m, 2H), 2.33 (m, 2H), 2.78 (s, 3H), 2.97 (m, 2H) , 4.32 (t, 1H), 6.80 (m, 1H), 7.03 (d, 1H), 7.17 (m, 1H), 7.26 (m, 4H)

실시예Example 3: N,N- 3: N, N- 디이소프로필Diisopropyl -3-(2--3- (2- 하이드록시Hydroxy -5--5- 메틸페닐Methylphenyl )-3-) -3- 페닐프로판아민(I)의Of phenylpropanamine (I) 제조 1 Manufacture 1

실시예 2에서 얻어진 2-(3-메탄술포닐옥시-1-페닐-프로필)-4-메틸페놀 40g (99.11mmol)을 메탄올과 물의 2:1 혼합 용매 450ml에 녹이고 수산화나트륨 19.82g (495.55mmol)을 가하였다. 반응용액을 6시간 동안 환류시킨 후 실온으로 냉각시키고 용매를 감압하에서 제거하여 반응용액을 1/3로 농축한다. 디클로로메탄 600ml와 물 300ml를 가하여 유기층을 추출하고 물 300ml로 다시 세척한다. 얻어진 유기층을 무수 황산 마그네슘으로 건조시키고 감압 하에서 농축시켜 고체상의 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민 30.0g(수율 93.0%)을 얻었다. 40 g (99.11 mmol) of 2- (3-methanesulfonyloxy-1-phenyl-propyl) -4-methylphenol obtained in Example 2 were dissolved in 450 ml of a 2: 1 mixed solvent of methanol and water, and 19.82 g (495.55 mmol) of sodium hydroxide were dissolved. ) Was added. The reaction solution was refluxed for 6 hours, cooled to room temperature, the solvent was removed under reduced pressure, and the reaction solution was concentrated to 1/3. 600 ml of dichloromethane and 300 ml of water were added to extract the organic layer and washed again with 300 ml of water. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 30.0 g (yield 93.0%) of N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine as a solid. .

1H NMR (CDCl3) δ=1.10 (dd, 12H), 2.11 (s, 3H), 2.11 (m, 1H), 2.37 (m, 2H), 2.73(m, 1H), 3.22 (m, 2H), 4.48 (dd, 1H), 6.54 (s, 1H), 6.82 (m, 2H), 7.22 (m, 2H), 7.32(d, 4H) 1 H NMR (CDCl 3 ) δ = 1.10 (dd, 12H), 2.11 (s, 3H), 2.11 (m, 1H), 2.37 (m, 2H), 2.73 (m, 1H), 3.22 (m, 2H) , 4.48 (dd, 1H), 6.54 (s, 1H), 6.82 (m, 2H), 7.22 (m, 2H), 7.32 (d, 4H)

실시예Example 4: 2-(3-p- 4: 2- (3-p- 톨루엔술포닐옥시Toluenesulfonyloxy -1--One- 페닐Phenyl -프로필)-4--Propyl) -4- 메틸페놀(V)의Of methylphenol (V) 제조 2 Manufacture 2

실시예 1에서 얻어진 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀 40g (165.07mmol)을 고압반응기내에서 아세토니트릴 300ml에 용해시킨 후 빙냉하에서 트리에틸아민 40.09g (396.17mmol)과 p-톨루엔술포닐 클로라이드 69.24g (363.15mmol)를 순차적으로 가하였다. 반응용액의 온도를 서서히 실온으로 올리면서 1시간 동안 교반한 후 N,N-디이소프로필아민 300ml를 가하고 반응용기를 밀봉하였다. 고압반응기의 외부온도를 80℃로 올려 60시간 동안 교반한 후 반응기의 온도를 다시 실온으로 냉각하였다. 용매를 감압하에서 제거한 후 디클로로메탄 600ml를 가하고 묽은 수산화나트륨 수용액 300ml와 묽은 염산 용액 300ml를 사용하여 순차적으로 세척하였다. 용매를 감압하에서 제거하여 묽은 염산용액 500ml에 녹인 후 디이소프로필 에테르 300ml로 세척하고 수산화나트륨을 가하여 수용액을 염기성으로 전환시켰다. 수용액을 디클로로메탄 600ml롤 추출한 후 무수 황산 마그네슘으로 건조시키고 감압 하에서 농축시켜 오일상의 2-(3-p-톨루엔술포닐옥시-1-페닐-프로필)-4-메틸페놀 60.57g(수율 76.5%)을 얻었다. 40 g (165.07 mmol) of 2- (3-hydroxy-1-phenyl-propyl) -4-methylphenol obtained in Example 1 were dissolved in 300 ml of acetonitrile in a high-pressure reactor, and then 40.09 g (396.17) of triethylamine under ice-cooling. mmol) and 69.24 g (363.15 mmol) of p-toluenesulfonyl chloride were added sequentially. After stirring for 1 hour while gradually raising the temperature of the reaction solution to room temperature, 300 ml of N, N-diisopropylamine was added and the reaction vessel was sealed. After raising the external temperature of the high-pressure reactor to 80 ° C and stirring for 60 hours, the temperature of the reactor was cooled to room temperature again. After the solvent was removed under reduced pressure, 600 ml of dichloromethane was added, and the mixture was washed sequentially using 300 ml of diluted aqueous sodium hydroxide solution and 300 ml of diluted hydrochloric acid solution. The solvent was removed under reduced pressure, dissolved in 500 ml of dilute hydrochloric acid solution, washed with 300 ml of diisopropyl ether, and sodium hydroxide was added to convert the aqueous solution to basic. The aqueous solution was extracted with 600 ml of dichloromethane, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give 60.57 g of 2- (3-p-toluenesulfonyloxy-1-phenyl-propyl) -4-methylphenol as an oil (yield 76.5%). Got.

1H NMR (CDCl3) δ=0.83 (d, 12H), 2.11 (s, 3H), 2.19 (m, 2H), 2.28 (s, 3H), 2.88(m, 2H), 4.06 (t, 1H), 6.74 (s, 2H), 6.98(s, 2H), 7.08 (m, 4H), 7.13 (d, 2H), 7.63 (d, 2H) 1 H NMR (CDCl 3 ) δ = 0.83 (d, 12H), 2.11 (s, 3H), 2.19 (m, 2H), 2.28 (s, 3H), 2.88 (m, 2H), 4.06 (t, 1H) , 6.74 (s, 2H), 6.98 (s, 2H), 7.08 (m, 4H), 7.13 (d, 2H), 7.63 (d, 2H)

실시예Example 5: N,N- 5: N, N- 디이소프로필Diisopropyl -3-(2--3- (2- 하이드록시Hydroxy -5--5- 메틸페닐Methylphenyl )-3-) -3- 페닐프로판아민(I)의Of phenylpropanamine (I) 제조 2 Manufacture 2

실시예 4에서 얻어진 2-(3-p-톨루엔술포닐옥시-1-페닐-프로필)-4-메틸페놀 50g (104.23mmol)을 메탄올과 물의 2:1 혼합용매 450ml에 녹이고 수산화나트륨 20.85g (521.17mmol)을 가하였다. 반응용액을 6시간 동안 환류한 후 실온으로 냉각시킨 후 용매를 감압하에서 제거하여 반응용액을 1/3로 농축한다. 디클로로메탄 600ml와 물 300ml를 가하여 유기층을 추출하고 물 300ml로 다시 세척한다. 얻어진 유기층을 무수 황산 마그네슘으로 건조시키고 감압 하에서 농축시켜 고체상의 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민 31.31g(수율 92.3%)을 얻었다. 50 g (104.23 mmol) of 2- (3-p-toluenesulfonyloxy-1-phenyl-propyl) -4-methylphenol obtained in Example 4 were dissolved in 450 ml of a 2: 1 mixed solvent of methanol and water, and 20.85 g of sodium hydroxide ( 521.17 mmol) was added. The reaction solution was refluxed for 6 hours, cooled to room temperature, the solvent was removed under reduced pressure, and the reaction solution was concentrated to 1/3. 600 ml of dichloromethane and 300 ml of water were added to extract the organic layer and washed again with 300 ml of water. The resulting organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give 31.31 g (yield 92.3%) of N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine as a solid. .

1H NMR (CDCl3) δ=1.10 (dd, 12H), 2.11 (s, 3H), 2.11 (m, 1H), 2.37 (m, 2H), 2.73(m, 1H), 3.22 (m, 2H), 4.48 (dd, 1H), 6.54 (s, 1H), 6.82 (m, 2H), 7.22 (m, 2H), 7.32(d, 4H) 1 H NMR (CDCl 3 ) δ = 1.10 (dd, 12H), 2.11 (s, 3H), 2.11 (m, 1H), 2.37 (m, 2H), 2.73 (m, 1H), 3.22 (m, 2H) , 4.48 (dd, 1H), 6.54 (s, 1H), 6.82 (m, 2H), 7.22 (m, 2H), 7.32 (d, 4H)

본 발명은 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 소듐보로히드리드와 반응시켜 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀을 제조하고, 알킬 또는 아릴술포닐 클로라이드와 N,N-디이소프로필아민을 순차적으로 반응시켜 화학식 (V)로 표시되는 화합물을 제조하고, 메탄올 수용액에서 수산화염을 반응시켜 화학식 (I)로 표시되는 (N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민을 고수율로 용이하게 제조하는 방법을 제공하는 효과를 가진다. The present invention relates to 2- (3-hydroxy-1) represented by formula (IV) by reacting 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by formula (III) with sodium borohydride. -Phenyl-propyl) -4-methylphenol was prepared, and a compound represented by the formula (V) was prepared by sequentially reacting alkyl or arylsulfonyl chloride with N, N-diisopropylamine, and in aqueous methanol solution. Providing a method for easily producing (N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine represented by formula (I) by reacting a flame with high yield Has an effect.

화학식 (I)로 표시되는 톨테로딘 라세미체를 제조하는 방법에 관련된 선행기술의 경우 수분과 접촉시 화재를 유발하는 시약이나 유독성 기체를 발생시키는 시약을 사용하거나, 고압의 수소를 사용하면서도 반응공정이 길거나 어려워 실제 대량 공정에 적용하기 어렵다는 문제가 있다. 그러나, 본 발명은 이러한 바람직하지 않은 시약을 사용하지 않으며 그리고 고압의 수소를 사용하지 않으면서도 반응공정이 단축된 새로운 공정으로 고품질의 화학식 (I)로 표시되는 톨테로딘 라세미체를 제조할 수 있다는 장점을 갖는다.Prior art related to the method for preparing tolterodine racemate represented by formula (I) uses a reagent that causes a fire or a toxic gas when contacted with water, or a reaction process using hydrogen at high pressure There is a problem that this is long or difficult, so it is difficult to apply to a real bulk process. However, the present invention does not use these undesirable reagents and can produce a high quality tolterodine racemate represented by the formula (I) in a new process with a shortened reaction process without using high pressure hydrogen. Has an advantage.

본 발명의 단순한 변형 내지 변경은 이 분야의 통상의 지식을 가진 자에 의하여 용이하게 이해될 수 있으며, 이러한 변형이나 변경은 모두 본 발명의 영역에 포함되는 것으로 볼 수 있다.Simple modifications and variations of the present invention can be readily understood by those skilled in the art, and all such variations or modifications can be considered to be included within the scope of the present invention.

Claims (6)

하기 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 소듐보로히드리드와 반응시켜 하기 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀을 제조하는 제1단계, 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by the following formula (III) is reacted with sodium borohydride to form 2- (3-hydroxy-1- represented by the following formula (IV) First step of preparing phenyl-propyl) -4-methylphenol, 상기 2-(3-히드록시-1-페닐-프로필)-4-메틸페놀을 알킬 또는 아릴 술포닐 클로라이드 및 트리에틸아민, 그리고 N,N-디이소프로필아민과 순차적으로 반응시켜 화학식 (V)로 표시되는 화합물을 제조하는 제2단계, 상기 알킬 또는 아릴 술포닐 클로라이드에서 알킬은 C1 내지 C4의 알킬이고, 아릴은 페닐 또는 C1 내지 C3의 알킬로 치환된 페닐기임, 및 The 2- (3-hydroxy-1-phenyl-propyl) -4-methylphenol is sequentially reacted with alkyl or aryl sulfonyl chloride and triethylamine, and N, N-diisopropylamine to give formula (V) In the second step of preparing a compound represented by, in the alkyl or aryl sulfonyl chloride, alkyl is C 1 to C 4 alkyl, aryl is phenyl or phenyl group substituted with C 1 to C 3 alkyl, and 화학식 (V)로 표시되는 화합물을 알칼리 금속의 수산화물과 반응시키는 제3단계:The third step of reacting a compound represented by the formula (V) with a hydroxide of an alkali metal: 로 이루어지는 하기 화학식 (I)로 표시되는 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민(톨테로딘 라세미체)의 제조 방법.A method for producing N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine (tolerodine racemate) represented by the following general formula (I).
Figure 112006002273936-pat00008
Figure 112006002273936-pat00009
Figure 112006002273936-pat00008
Figure 112006002273936-pat00009
Figure 112006002273936-pat00010
Figure 112006002273936-pat00011
Figure 112006002273936-pat00010
Figure 112006002273936-pat00011
상기 화학식 (V)에서, R은 C1 내지 C4의 알킬기, 페닐기 또는 C1 내지 C3의 알킬기로 치환된 페닐기이다.In the above formula (V), R is a phenyl group substituted with an alkyl group of C 1 to C 4 , a phenyl group or an alkyl group of C 1 to C 3 .
제1항에 있어서, 상기 화학식 (V)로 표시되는 화합물이 2-(3-메탄술포닐옥시-1-페닐-프로필)-4-메틸페놀 또는 2-(3-p-톨루엔술포닐옥시-1-페닐-프로필)-4-메틸페놀인 것을 특징으로 하는 톨테로딘 라세미체의 제조방법.The compound represented by the formula (V) is 2- (3-methanesulfonyloxy-1-phenyl-propyl) -4-methylphenol or 2- (3-p-toluenesulfonyloxy-. 1-phenyl-propyl) -4-methylphenol. A process for producing tolterodine racemate. 제1항에 있어서, 상기 알칼리 금속의 수산화물이 수산화리튬, 수산화나트륨, 또는 수산화칼륨인 것을 특징으로 하는 톨테로딘 라세미체의 제조방법.The method for producing tolterodine racemate according to claim 1, wherein the alkali metal hydroxide is lithium hydroxide, sodium hydroxide or potassium hydroxide. 제1항에 있어서, 상기 제2단계의 반응에 사용되는 용매가 테트라하이드로푸란, 디이소프로필에테르, 디옥산과 같은 에테르류, 아세토니트릴과 같은 니트릴류, 디클로로메탄, 클로로포름, 1,2-디클로로에탄과 같은 염화 탄화수소류, 디메틸아세트아미드, 디메틸포름아미드과 같은 아미드류로부터 선택되는 것을 특징으로 하는 톨테로딘 라세미체의 제조방법.The solvent used in the reaction of the second step is tetrahydrofuran, diisopropyl ether, ethers such as dioxane, nitriles such as acetonitrile, dichloromethane, chloroform, 1,2-dichloro A method for producing tolterodine racemates, which is selected from chlorinated hydrocarbons such as ethane, amides such as dimethylacetamide and dimethylformamide. 제4항에 있어서, 상기 용매가 아세토니트릴인 것을 특징으로 하는 톨테로딘 라세미체의 제조방법.The method for producing tolterodine racemate according to claim 4, wherein the solvent is acetonitrile. 제1항에 있어서, 상기 제3단계는 테트라하이드로푸란, 아세토니트릴, 에탄올, 및 메탄올로 이루어지는 군으로부터 선택되는 수용성 용매와 물의 혼합 용매 하에서 실시되는 것을 특징으로 하는 톨테로딘 라세미체의 제조방법.The method of claim 1, wherein the third step is performed under a mixed solvent of water-soluble solvent and water selected from the group consisting of tetrahydrofuran, acetonitrile, ethanol, and methanol.
KR1020060003528A 2006-01-12 2006-01-12 Method of preparing racemic tolterodine KR100686351B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060003528A KR100686351B1 (en) 2006-01-12 2006-01-12 Method of preparing racemic tolterodine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060003528A KR100686351B1 (en) 2006-01-12 2006-01-12 Method of preparing racemic tolterodine

Publications (1)

Publication Number Publication Date
KR100686351B1 true KR100686351B1 (en) 2007-02-22

Family

ID=38104471

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060003528A KR100686351B1 (en) 2006-01-12 2006-01-12 Method of preparing racemic tolterodine

Country Status (1)

Country Link
KR (1) KR100686351B1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000069771A (en) * 1996-12-31 2000-11-25 로렌스 티. 마이젠헬더 Process to Prepare Tolterodine
KR20020062669A (en) * 1999-12-30 2002-07-26 파마시아 에이비 Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process
US6822119B1 (en) * 2001-08-03 2004-11-23 Ranbaxy Laboratories Limited Process for the preparation of tolterodine
WO2005061432A1 (en) * 2003-12-24 2005-07-07 Cipla Limited Tolterodine, compositions and uses thereof, and preparation of the same
EP1584621A1 (en) * 2004-03-30 2005-10-12 Dipharma S.p.A. A process for the preparation of tolterodine and intermediates thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000069771A (en) * 1996-12-31 2000-11-25 로렌스 티. 마이젠헬더 Process to Prepare Tolterodine
KR20020062669A (en) * 1999-12-30 2002-07-26 파마시아 에이비 Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process
US6822119B1 (en) * 2001-08-03 2004-11-23 Ranbaxy Laboratories Limited Process for the preparation of tolterodine
WO2005061432A1 (en) * 2003-12-24 2005-07-07 Cipla Limited Tolterodine, compositions and uses thereof, and preparation of the same
EP1584621A1 (en) * 2004-03-30 2005-10-12 Dipharma S.p.A. A process for the preparation of tolterodine and intermediates thereof

Similar Documents

Publication Publication Date Title
CN101993406B (en) Indoline compound with optical activity and preparation method thereof
JP2008088159A (en) Process for synthesis of o-desmethylvenlafaxine
CA2456293A1 (en) Process for the preparation of tolterodine
KR101308258B1 (en) A novel method of making Endoxifen
JP5646706B2 (en) Method for producing C-glycoside derivative
EP2349976B1 (en) A process for producing (s)-3-[(1-dimethylamino)ethyl]phenyl-n-ethyl-n-methyl-carbamate via novel intermediates
US8299305B2 (en) Method for preparing atomoxetine
WO2007026373A2 (en) Process for preparing rivastigmine
KR100686351B1 (en) Method of preparing racemic tolterodine
CN112939911A (en) Chiral resolution process for preparing key intermediate of levo-Corey lactone
WO2012089177A1 (en) Method of producing (2r,3r)-na-dimethyl-3-(3-hydroxyphenyi)-2-methylpentylamine (tapentadol)
US7473805B2 (en) Process for obtaining tolterodine
KR100717361B1 (en) Method of preparing racemic tolterodine and its intermediate
CA2581781A1 (en) Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide
US9145353B2 (en) Method of preparing (S)-2-amino-5-methoxytetralin hydrochloride
JPWO2011118625A1 (en) Process for producing optically active N-monoalkyl-3-hydroxy-3-arylpropylamine compound
WO2009011551A2 (en) Process for the efficient preparation of 3-hydroxy pyrrolidine and derivatives thereof
JP2009535398A (en) Process for producing tolterodine or a salt thereof, and intermediate for production
KR100701743B1 (en) Novel Making Proces of the Bambuterol
KR20180050091A (en) A method for preparation of (S)-N1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrocholoride
KR101465777B1 (en) Novel Process for Preparing (+)-Polyoxamic acid
CZ293791B6 (en) Process for preparing N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropyl amine in racemic or optically active form thereof
US7390926B2 (en) Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3
JP2004269376A (en) Method for producing 1-formyl-3-(3,4-methylenedioxyphenyl)propene derivative
KR100647068B1 (en) Process for preparing racemic n,n-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20111125

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20130213

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee